Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.145
+0.075 (7.01%)
At close: Apr 29, 2025, 4:00 PM
1.130
-0.015 (-1.31%)
After-hours: Apr 29, 2025, 5:28 PM EDT

Allarity Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Selling, General & Admin
11.4410.039.9612.364.1
Upgrade
Research & Development
6.897.97.6414.24.22
Upgrade
Other Operating Expenses
-0.8-0.8-0.71--
Upgrade
Operating Expenses
17.5417.1316.8926.568.32
Upgrade
Operating Income
-17.54-17.13-16.89-26.56-8.32
Upgrade
Interest Expense
-0.65-0.5-0.22-0.59-0.32
Upgrade
Interest & Investment Income
0.530.020.03--
Upgrade
Currency Exchange Gain (Loss)
-0.210.13-0.91-0.10.06
Upgrade
Other Non Operating Income (Expenses)
2.685.6517.130.351.56
Upgrade
EBT Excluding Unusual Items
-15.19-11.82-0.87-26.88-7.02
Upgrade
Gain (Loss) on Sale of Investments
---0.12-0.50.71
Upgrade
Gain (Loss) on Sale of Assets
--1.781.01-
Upgrade
Asset Writedown
-9.7--17.57--
Upgrade
Other Unusual Items
---0.8-0.14-0.11
Upgrade
Pretax Income
-24.9-11.82-17.58-26.52-6.42
Upgrade
Income Tax Expense
-0.380.08-1.520.130.2
Upgrade
Earnings From Continuing Operations
-24.52-11.9-16.06-26.65-6.62
Upgrade
Minority Interest in Earnings
----0.02
Upgrade
Net Income
-24.52-11.9-16.06-26.65-6.6
Upgrade
Preferred Dividends & Other Adjustments
0.648.524.99--
Upgrade
Net Income to Common
-25.15-20.42-21.05-26.65-6.6
Upgrade
Shares Outstanding (Basic)
2----
Upgrade
Shares Outstanding (Diluted)
2----
Upgrade
EPS (Basic)
-15.65----
Upgrade
EPS (Diluted)
-15.65----
Upgrade
Free Cash Flow
-17.65-12.75-16.84-14.89-7.25
Upgrade
Free Cash Flow Per Share
-10.98----
Upgrade
EBITDA
-17.53-17.09-16.83-26.45-8.27
Upgrade
D&A For EBITDA
0.010.040.060.110.05
Upgrade
EBIT
-17.54-17.13-16.89-26.56-8.32
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q